The Delhi High Court has rejected a trademark claim by Alkem Laboratories, a pharmaceutical company, over the use of the term “A TO Z” for its products. The court ruled that alphabets are public property and cannot be monopolized by a single entity. <\/p>\n
Alkem Laboratories had filed a lawsuit against another pharmaceutical company, Unichem Laboratories, alleging that Unichem’s use of the term “A TO Z” for its products infringed on Alkem’s trademark. Alkem claimed that it had been using the term “A TO Z” for its products since 1972 and had acquired a reputation and goodwill in the market.<\/p>\n
However, the court rejected Alkem’s claim, stating that alphabets are public property and cannot be trademarked. The court observed that the term “A TO Z” is a common phrase used to denote a comprehensive range of products or services, and its use by Unichem did not infringe on Alkem’s trademark.<\/p>\n
The court also noted that Alkem had not provided sufficient evidence to prove that its use of the term “A TO Z” had acquired a distinctive character and was exclusively associated with its products. The court held that the term “A TO Z” is a descriptive phrase and not a distinctive trademark.<\/p>\n
The judgment is significant as it sets a precedent for the use of common phrases and alphabets in trademarks. It emphasizes that companies cannot claim exclusive rights over public property, such as alphabets, and that trademark law is intended to protect distinctive signs and symbols that identify a particular business or product.<\/p>\n
The court’s decision is also a victory for Unichem Laboratories, which can continue to use the term “A TO Z” for its products without fear of infringement. The judgment highlights the importance of ensuring that trademark claims are not used to stifle competition or restrict the use of common language.<\/p>\n
In conclusion, the Delhi High Court’s rejection of Alkem’s trademark claim over the term “A TO Z” is a significant ruling that emphasizes the public nature of alphabets and common phrases. The judgment sets a precedent for the use of trademarks and highlights the importance of protecting distinctive signs and symbols that identify a particular business or product.<\/p>\n","protected":false},"excerpt":{"rendered":"
The Delhi High Court has rejected a trademark claim by Alkem Laboratories, a pharmaceutical company, over the use of the term “A TO Z” for its products. The court ruled that alphabets are public property and cannot be monopolized by a single entity. Alkem Laboratories had filed a lawsuit against another pharmaceutical company, Unichem Laboratories, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[22,2],"tags":[],"class_list":["post-89849","post","type-post","status-publish","format-standard","hentry","category-alkem","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89787,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/12\/alkems-renocia-kit-offers-a-cyclical-nutritional-supplement-therapy-designed-to-promote-healthy-hair-growth\/","url_meta":{"origin":89849,"position":0},"title":"Alkem’s Renocia kit offers a cyclical nutritional supplement therapy designed to promote healthy hair growth.","author":"Team Small News","date":"January 12, 2026","format":false,"excerpt":"Alkem Laboratories has launched a new product called Renocia cyclical therapy kit, a weekly nutritional supplementation regimen designed to support hair growth, strengthen hair follicles, and manage hair loss. The kit contains a set of vegetarian-sourced supplements, including vitamins, minerals, and amino acids, which are taken on specific days of\u2026","rel":"","context":"In "Alkem"","block_context":{"text":"Alkem","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/alkem\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89827,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/20\/delhi-high-court-rejects-interim-injunction-rules-that-letters-a-and-z-are-not-exclusive-property\/","url_meta":{"origin":89849,"position":1},"title":"Delhi High Court Rejects Interim Injunction, Rules That Letters ‘A’ and ‘Z’ Are Not Exclusive Property.","author":"Team Small News","date":"January 20, 2026","format":false,"excerpt":"The Delhi High Court has made a significant ruling in a trademark infringement case, stating that the use of letters \"A\" and \"Z\" cannot be monopolized by a single entity. The court refused an interim injunction sought by a company that claimed exclusive rights to the use of these letters\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89721,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/30\/delhi-high-court-prohibits-dr-reddys-from-using-the-sun-trademark-on-sunscreen-product-labels\/","url_meta":{"origin":89849,"position":2},"title":"Delhi High Court prohibits Dr. Reddy’s from using the ‘SUN’ trademark on sunscreen product labels.","author":"Team Small News","date":"December 30, 2025","format":false,"excerpt":"The Delhi High Court has issued a restraining order against Dr. Reddy's Laboratories, preventing the company from using the 'SUN' mark on their sunscreen product labels. This decision comes after a lawsuit was filed by Sun Pharmaceutical Industries, which claimed that Dr. Reddy's was infringing on their trademark rights. Sun\u2026","rel":"","context":"In "Dr Reddy's"","block_context":{"text":"Dr Reddy's","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/dr-reddys\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":89838,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/22\/alkem-laboratories-slapped-with-%e2%82%b92-35-crore-gst-demand-notice-and-penalty-by-additional-commissioner-as-reported-by-scanx-trade\/","url_meta":{"origin":89849,"position":3},"title":"Alkem Laboratories slapped with \u20b92.35 crore GST demand notice and penalty by Additional Commissioner, as reported by scanx.trade","author":"Team Small News","date":"January 22, 2026","format":false,"excerpt":"Alkem Laboratories, a prominent Indian pharmaceutical company, has received a Goods and Services Tax (GST) demand order from the Additional Commissioner, totaling \u20b92.35 crore, along with a penalty. The order, which was issued on [date], has sparked concerns among the company's stakeholders and has the potential to impact its financial\u2026","rel":"","context":"In "Alkem"","block_context":{"text":"Alkem","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/alkem\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89748,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/04\/delhi-high-court-bars-dr-reddys-from-producing-venusia-sunscreens-bearing-the-sun-logo\/","url_meta":{"origin":89849,"position":4},"title":"Delhi High Court bars Dr Reddy’s from producing VENUSIA sunscreens bearing the SUN logo.","author":"Team Small News","date":"January 4, 2026","format":false,"excerpt":"The Delhi High Court has issued an interim order restraining Dr. Reddy's Laboratories from manufacturing and selling its VENUSIA sunscreens with a label that includes the word \"SUN\". The court's decision comes in response to a lawsuit filed by Glenmark Pharmaceuticals, which claims that Dr. Reddy's is infringing on its\u2026","rel":"","context":"In "Glenmark"","block_context":{"text":"Glenmark","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/glenmark\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89757,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/06\/sun-pharmaceutical-industries-suffers-loss-in-trademark-dispute-as-bombay-high-court-rules-esiraft-and-raciraft-do-not-bear-deceptive-similarities\/","url_meta":{"origin":89849,"position":5},"title":"Sun Pharmaceutical Industries suffers loss in trademark dispute as Bombay High Court rules EsiRaft and Raciraft do not bear deceptive similarities.","author":"Team Small News","date":"January 6, 2026","format":false,"excerpt":"The Bombay High Court has ruled in favor of Eris Lifesciences, dismissing Sun Pharmaceutical's claim that Eris's medication \"EsiRaft\" infringed on Sun Pharma's trademark for their medication \"Raciraft\". The court found that the names \"EsiRaft\" and \"Raciraft\" are not deceptively similar, and therefore, Eris Lifesciences did not infringe on Sun\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89849"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89849\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}